hotspot -WSS

hotspot

author：hotspot 2025-10-02 00:43:23 - browse：62485

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： President Biden's budget: Here's what you might have missed

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

NYU radiologists take on the challenge of expensive MRI machines

As AI in medicine takes off, can 'human in the loop' prevent harm?

David Sabatini, ex

First U.S. drug developed to treat liver disease MASH is approved

Readout Newsletter: CAR

hotspot

hotspot

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

In key trial, Verve's treatment lowers cholesterol levels in patients

Sports medicine is finally prioritizing gender equality

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Anesthesiologist group: stop taking Ozempic before surgery

In key trial, Verve's treatment lowers cholesterol levels in patients

Apple is now the first public company to be valued at $3 trillion

EPA limits use of carcinogenic gas for sterilizing medical devices

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA advisers back CAR

hotspot

Congress must reauthorize a committee to support older Americans

Ransomware attacks on hospitals: Study outlines patient impact

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

U.K. considers world's first use of meningitis vaccine to address gonorrhea

FDA's Woodcock to retire early next year

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

hotspot

knowledge

focus

entertainment